2SEVENTY BIO INC's ticker is and the CUSIP is 901384107. A total of 147 filers reported holding 2SEVENTY BIO INC in Q2 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 684,996 | $9,885,521 | 8.20% |
| Madison Avenue Partners, LP | 1,199,832 | $11,242,426 | 1.99% |
| Newtyn Management, LLC | 882,134 | $8,265,596 | 1.71% |
| AlphaCentric Advisors LLC | 180,000 | $1,686,600 | 1.67% |
| Bain Capital Life Sciences Investors, LLC | 1,408,901 | $13,201 | 1.48% |
| Casdin Capital, LLC | 1,850,000 | $17,334,500 | 1.34% |
| CHI Advisors LLC | 333,252 | $3,122,571 | 0.83% |
| Birchview Capital, LP | 59,833 | $561 | 0.40% |
| TANG CAPITAL MANAGEMENT LLC | 250,000 | $2,342,500 | 0.34% |
| EcoR1 Capital, LLC | 1,143,494 | $10,714,539 | 0.33% |